iron chelators
Cellular interactions with iron chelators
218
Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran
8
The biological development of hydroxypyridinone iron chelators
251
EFFECT OF IRON OVERLOAD AND IRON CHELATORS ON ANTI MÜLLERIAN HORMONE LEVEL IN EGYPTIAN FEMALE PATIENTS WITH TRANSFUSION DEPENDENT β THALASSEMIA
5
Mechanisms of apoptotic induction by iron chelators
280
A Review on Iron Chelators in Treatment of Iron Overload Syndromes
9
Oral Iron Chelators and the Treatment of Iron Overload in Pediatric Patients With Chronic Anemia
6
A Single Biosynthetic Gene Cluster Is Responsible for the Production of Bagremycin Antibiotics and Ferroverdin Iron Chelators
15
Evaluation of recombinant human transferrin (DeltaFerrin(TM)) as an iron chelator in serum free media for mammalian cell culture
9
THE INVESTIGATION OF THE EFFECT OF GREEN TEA ON THE IRON OVERLOAD IN PATIENTS WITH MAJOR THALASSEMIA UNDER REGULAR BLOOD TRANSFUSIONHossein Shahdadi , Sadegh Dehghan Mehr* , Mojgan Rahnama, Mahdi Afshari DOWNLOAD/VIEW
8
Role of oxidants in DNA damage Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke
7
Targeting cancer by binding iron: Dissecting cellular signaling pathways
32
Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics
20
Modulating Iron for Metabolic Support of TB Host Defense
18
The use of metal chelators in radiolabelling of platelets and their effects on cell function
270
AYURVEDIC MANAGEMENT OF THALASSEMIA MAJOR (BEEJA DUSHTIJANYA PANDU) AS AN ADJUVANT THERAPY - A CASE STUDY .......
7
Iron and leukemia: new insights for future treatments
17
Acute iron poisoning Rescue with macromolecular chelators
6
<p>BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease</p>
10
Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives
11